RS63270B1 - Jedinjenja za upotrebu u tretmanu ili profilaksi bola, inflamacije i/ili autoimuniteta - Google Patents
Jedinjenja za upotrebu u tretmanu ili profilaksi bola, inflamacije i/ili autoimunitetaInfo
- Publication number
- RS63270B1 RS63270B1 RS20220510A RSP20220510A RS63270B1 RS 63270 B1 RS63270 B1 RS 63270B1 RS 20220510 A RS20220510 A RS 20220510A RS P20220510 A RSP20220510 A RS P20220510A RS 63270 B1 RS63270 B1 RS 63270B1
- Authority
- RS
- Serbia
- Prior art keywords
- polymorph
- pain
- polymorphic form
- treatment
- prophylaxis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/32—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C235/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/22—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19153315 | 2019-01-23 | ||
| EP20703152.7A EP3860582B1 (en) | 2019-01-23 | 2020-01-22 | Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity |
| PCT/EP2020/051528 WO2020152226A1 (en) | 2019-01-23 | 2020-01-22 | Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS63270B1 true RS63270B1 (sr) | 2022-06-30 |
Family
ID=65228356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20220510A RS63270B1 (sr) | 2019-01-23 | 2020-01-22 | Jedinjenja za upotrebu u tretmanu ili profilaksi bola, inflamacije i/ili autoimuniteta |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US11891350B2 (enExample) |
| EP (1) | EP3860582B1 (enExample) |
| JP (2) | JP7611148B2 (enExample) |
| KR (1) | KR20210119403A (enExample) |
| CN (1) | CN113329746B (enExample) |
| AU (1) | AU2020210831B2 (enExample) |
| BR (1) | BR112021019476A2 (enExample) |
| CA (1) | CA3118996A1 (enExample) |
| DK (1) | DK3860582T3 (enExample) |
| ES (1) | ES2913977T3 (enExample) |
| IL (1) | IL282718B2 (enExample) |
| PL (1) | PL3860582T3 (enExample) |
| PT (1) | PT3860582T (enExample) |
| RS (1) | RS63270B1 (enExample) |
| SG (1) | SG11202111773QA (enExample) |
| WO (1) | WO2020152226A1 (enExample) |
| ZA (1) | ZA202107346B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3939578A1 (en) * | 2020-07-13 | 2022-01-19 | Novaremed Ltd. | Compounds for treatment or prevention of an infection resulting from a coronavirus and/or a coronavirus-induced disease |
| WO2026037478A1 (en) | 2023-08-11 | 2026-02-19 | Novaremed AG | (s,s)-(3-o-(propan-2-ol)-2-amino-prop-1-yl-4-hydroxybenzene and its analogues for the treatment of chronic pain |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7642290B2 (en) | 2002-10-03 | 2010-01-05 | Novaremed Limited | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection |
| US7674829B2 (en) | 2004-03-26 | 2010-03-09 | Novaremed Limited | Compounds for the treatment of AIDS and other viral diseases |
| GB0804213D0 (en) | 2008-03-06 | 2008-04-16 | New Era Biotech Ltd | A method of printing or preventing pain |
| WO2011030205A1 (en) | 2009-09-09 | 2011-03-17 | Novaremed Ltd. | N-substituted benzenepropanamide or benzenepropenamide for use in the treatment of pain and inflammation |
| US8802734B2 (en) | 2009-09-09 | 2014-08-12 | Novaremed Limited | Method of treating or preventing pain |
| GB0916073D0 (en) | 2009-09-14 | 2009-10-28 | Cintec Int Ltd | Improvements in and relating to building anchor systems |
| CN103998420B (zh) * | 2011-12-08 | 2018-04-17 | 诺瓦麦有限公司 | (s)2‑n(3‑o‑(丙‑2‑醇)‑1‑丙基‑4‑羟基苯)‑3‑苯基丙酰胺的分离的立体异构形式 |
-
2020
- 2020-01-22 RS RS20220510A patent/RS63270B1/sr unknown
- 2020-01-22 KR KR1020217023524A patent/KR20210119403A/ko not_active Ceased
- 2020-01-22 BR BR112021019476A patent/BR112021019476A2/pt unknown
- 2020-01-22 PT PT207031527T patent/PT3860582T/pt unknown
- 2020-01-22 SG SG11202111773QA patent/SG11202111773QA/en unknown
- 2020-01-22 US US17/295,788 patent/US11891350B2/en active Active
- 2020-01-22 AU AU2020210831A patent/AU2020210831B2/en active Active
- 2020-01-22 CA CA3118996A patent/CA3118996A1/en active Pending
- 2020-01-22 DK DK20703152.7T patent/DK3860582T3/da active
- 2020-01-22 JP JP2021543276A patent/JP7611148B2/ja active Active
- 2020-01-22 ES ES20703152T patent/ES2913977T3/es active Active
- 2020-01-22 EP EP20703152.7A patent/EP3860582B1/en active Active
- 2020-01-22 CN CN202080010393.8A patent/CN113329746B/zh active Active
- 2020-01-22 IL IL282718A patent/IL282718B2/en unknown
- 2020-01-22 PL PL20703152.7T patent/PL3860582T3/pl unknown
- 2020-01-22 WO PCT/EP2020/051528 patent/WO2020152226A1/en not_active Ceased
-
2021
- 2021-09-23 ZA ZA2021/07346A patent/ZA202107346B/en unknown
-
2024
- 2024-12-23 JP JP2024226332A patent/JP2025036479A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PT3860582T (pt) | 2022-07-08 |
| ES2913977T3 (es) | 2022-06-07 |
| KR20210119403A (ko) | 2021-10-05 |
| SG11202111773QA (en) | 2021-11-29 |
| US20220002228A1 (en) | 2022-01-06 |
| CA3118996A1 (en) | 2020-07-30 |
| US11891350B2 (en) | 2024-02-06 |
| JP7611148B2 (ja) | 2025-01-09 |
| JP2025036479A (ja) | 2025-03-14 |
| EP3860582A1 (en) | 2021-08-11 |
| IL282718A (en) | 2021-06-30 |
| PL3860582T3 (pl) | 2022-08-01 |
| JP2022518288A (ja) | 2022-03-14 |
| ZA202107346B (en) | 2023-10-25 |
| AU2020210831B2 (en) | 2025-02-13 |
| BR112021019476A2 (pt) | 2021-11-30 |
| EP3860582B1 (en) | 2022-05-04 |
| CN113329746A (zh) | 2021-08-31 |
| IL282718B1 (en) | 2024-04-01 |
| WO2020152226A1 (en) | 2020-07-30 |
| IL282718B2 (en) | 2024-08-01 |
| CN113329746B (zh) | 2025-05-02 |
| AU2020210831A1 (en) | 2021-05-20 |
| DK3860582T3 (da) | 2022-05-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5371790B2 (ja) | 睡眠および認知に関するうつ病における残存症状の治療のための組み合わされたセロトニン再取り込み、５−ｈｔ３および５−ｈｔ１ａ活性を有する化合物としての１−［２−（２，４−ジメチルフェニルスルファニル）フェニル］ピペラジン | |
| JP2025036479A (ja) | 疼痛、炎症および／または自己免疫の処置または予防における使用のための化合物 | |
| KR101688996B1 (ko) | 통증 치료에 있어서 트라마돌 및 셀레콕시브를 포함하는 조성물 | |
| RS55147B1 (sr) | Terapeutske upotrebe jedinjenja koja imaju kombinovanu sert, 5-ht3 i 5-ht1a aktivnost | |
| RS56523B1 (sr) | Tapentadol za sprečavanje i lečenje depresije i anksioznosti | |
| JP2018021023A (ja) | （ｓ）２−ｎ（３−ｏ−（プロパン２−オール）−１−プロピル−４−ヒドロキシベンゼン）−３−フェニルプロピルアミドの単離された立体異性体型 | |
| EP2475361B1 (en) | N-substituted benzenepropanamides for use in the treatment of pain and inflammation | |
| KR20080037055A (ko) | 물질 관련 장애를 치료하는 방법 | |
| HUP0302970A2 (hu) | Aminosavak felhasználása fájdalom kezelésére, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| HK40061961A (en) | Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity | |
| HK40061961B (en) | Compounds for use in the treatment or prophylaxis of pain, inflammation and/or autoimmunity | |
| CN111050800B (zh) | 血清素3受体激动剂对疼痛的治疗 | |
| ZA200404813B (en) | Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine | |
| JP6116675B2 (ja) | （１ｒ，４ｒ）−６’−フルオロ−Ｎ，Ｎ−ジメチル−４−フェニル−４’，９’−ジヒドロ−３’Ｈ−スピロ［シクロヘキサン−１，１’−ピラノ［３，４，ｂ］インドール］−４−アミンおよびサリチル酸成分を含む医薬組成物 | |
| WO2012136351A1 (en) | Tapentadol for treating pain associated with trigeminal neuralgia | |
| JP2005538956A (ja) | １−ジメチルアミノ−３−（３−メトキシ−フェニル）−２−メチル−ペンタン−３−オール及び３−（３−ジメチルアミノ−１−エチル−１−ヒドロキシ−２−メチル−プロピル）−フェノールの有効物質塩及びエステル | |
| JP2018501314A (ja) | ジアリールメチリデンピペリジン誘導体およびデルタオピオイド受容体アゴニストとしてそれらの使用 | |
| CN101272684A (zh) | 治疗神经病及相关病症的方法及组合物 | |
| EP2353594A1 (en) | Compositions comprising tramadol and the co-crystal of celecoxib and L-proline in the treatment of pain | |
| HK1173379B (en) | Compositions comprising tramadol and celecoxib in the treatment of pain | |
| MX2008001186A (es) | Metodos y composiciones para el tratamiento de neuropatias y desordenes relacionados |